Work

844P KRAS mutant epithelial ovarian carcinomas (EOC) represent distinct genomic genotypes

Year: 2020

Type: article

Study design: Observational Study

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2020.08.983

Authors: K.A. Kilowski, M. Dietrich, J. Xiu, N. Jones, M. Powell, V.B. Galvan Turner, B. Erickson, D. Mutch, P. Thaker, A. ElNaggar, D. Dizon, S. Ahmad, T. Herzog, W.M. Korn, R.W. Holloway

Institutions: AdventHealth Orlando, AdventHealth, Florida Cancer Specialists & Research Institute, Caris Life Sciences (United States), USA Mitchell Cancer Institute, University of South Alabama, Washington University in St. Louis, West Virginia University, University of Minnesota, Washington University Medical Center, Brown University, Lifespan, University of Cincinnati, University of Cincinnati Medical Center

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Amgen, Eli Lilly and Company, Pfizer, AstraZeneca, Gilead Sciences, Novocure, Clovis Oncology, Incyte, University College London, PharmaMar

OpenAlex ID: W3088096243

FWCI:

Cites:

Cited by:

Related to: 10